Life | Free Full-Text | Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
SciELO - Brasil - Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical ...
Definitions for clinically non-significant prostate cancer. | Download Table
Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score - Journal of Vascular and Interventional Radiology
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
Combination of 68Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis | Journal of Nuclear Medicine
Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience -
PLOS ONE: Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers
Distribution of patients with clinically significant prostate cancer... | Download Scientific Diagram
UCSF ci2 and DAIR Collaborate to Improve Detection of Clinically Significant Prostate Cancer from Prostate MRI | Center for Intelligent Imaging | UCSF Radiology
68Ga PSMA-11 PET/CT increases specificity for detection of clinically significant prostate cancer of lesions at multiparametric prostate MRI. | Journal of Nuclear Medicine
Distribution of patients with clinically significant prostate cancer... | Download Scientific Diagram
The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging | Scientific Reports
Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with “gray zone” PSA levels - European Journal of Radiology
Comparison of single-scanner single-protocol quantitative ADC measurements to ADC ratios to detect clinically significant prostate cancer - European Journal of Radiology
Detection of Clinically Significant Prostate Cancer: Short Dual–Pulse Sequence versus Standard Multiparametric MR Imaging—A Multireader Study | Radiology
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis | NEJM
Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning | Prostate Cancer and Prostatic Diseases
Detection of Clinically Significant Prostate Cancer by Systematic TRUS-Biopsies in a Population-Based Setting Over a 20 Year Period - Urology
SciELO - Brasil - The accuracy of pathological data for the prediction of insignificant prostate cancer The accuracy of pathological data for the prediction of insignificant prostate cancer
Under-detection of clinically significant prostate cancer resulting... | Download Scientific Diagram
Incidence of Clinically Significant Prostate Cancer After a Diagnosis of Atypical Small Acinar Proliferation, High-grade Prostatic Intraepithelial Neoplasia, or Benign Tissue - Urology
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The
